Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment
Y B Wang, Jiang Yajie, Manshu Zou, et al.
Behavioural Brain Research (2021) Vol. 420, pp. 113724-113724
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Depression and Its Phytopharmacotherapy—A Narrative Review
Łukasz Dobrek, Krystyna Głowacka
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4772-4772
Open Access | Times Cited: 61
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
Dmytro I. Boiko, Anastasiia D. Shkodina, Mohammad Mehedi Hasan, et al.
Neurochemical Research (2022) Vol. 47, Iss. 10, pp. 2909-2924
Open Access | Times Cited: 44
Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics
Shaoyi Fang, Zhibin Wu, Yali Guo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Chronotherapeutic Treatments for Psychiatric Disorders: A Narrative Review of Recent Literature
Leslie M. Swanson, Jessica R. Schubert, Greta B. Raglan, et al.
Current Psychiatry Reports (2025)
Closed Access | Times Cited: 1
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 30
Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy
Niloufar Targhazeh, Rüssel J. Reiter, Mahdi Rahimi, et al.
Biochimie (2022) Vol. 202, pp. 34-48
Closed Access | Times Cited: 26
Sleep deprivation leads to further impairment of hippocampal synaptic plasticity by suppressing melatonin secretion in the pineal gland of chronically unpredictable stress rats
Zirong Li, De-Guo Liu, Sheng Xie, et al.
European Journal of Pharmacology (2022) Vol. 930, pp. 175149-175149
Closed Access | Times Cited: 24
Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
Aditi Giri, Sidharth Mehan, Zuber Khan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 6, pp. 3867-3895
Closed Access | Times Cited: 5
Melatonin as a multifunctional modulator: emerging insights into its role in health, reproductive efficiency, and productive performance in livestock
Ali Afzal
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 4
Night shift hormone: How does melatonin affect depression?
Gita Kholghi, Maliheh Eskandari, Mohammad-Saleh Shokouhi Qare Saadlou, et al.
Physiology & Behavior (2022) Vol. 252, pp. 113835-113835
Closed Access | Times Cited: 19
Melatonin Ameliorates Neuropsychiatric Behaviors, Gut Microbiome, and Microbiota-Derived Metabolites in Rats with Chronic Sleep Deprivation
Bingcong Li, Yin-Ru Hsieh, Wen-De Lai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16820-16820
Open Access | Times Cited: 11
Melatonin influence on miRNA expression in sperm, hypothalamus, pre-frontal cortex and cerebellum of Wistar rats
Maria Inês Tiraboschi Ferro, Ingrid Morante, Fernanda Akane Nishino, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0312403-e0312403
Open Access
The Impact of Pharmacotherapy for Premenstrual Dysphoric Disorder on Sleep
Elisa M. S. Meth, Diana Aline Nôga, Manon Dubol, et al.
Sleep Medicine Reviews (2025) Vol. 80, pp. 102069-102069
Open Access
A Meta-Analysis of Melatonin Effects on Behavior of Rats Kept in Standard Conditions
N. V. Kuzmenko, В. А. Цырлин, М. Г. Плисс, et al.
Journal of Evolutionary Biochemistry and Physiology (2025) Vol. 61, Iss. 1, pp. 74-95
Closed Access
Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders
Marion Le Meur, Jaime Pignatelli, Paolo Blasi, et al.
Advanced Drug Delivery Reviews (2025), pp. 115561-115561
Open Access
Bioproduction of a Large-Scale Library of Tryptamine Derivatives for Neuropsychiatric Drug Screening
Jillian M. Hagel, Li‐Mei Chang, Jing Li, et al.
ACS Chemical Biology (2025)
Closed Access
Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy [Biochimie 200 (2022) 44–59]
Niloufar Targhazeh, Rüssel J. Reiter, Mahdi Rahimi, et al.
Biochimie (2022) Vol. 200, pp. 44-59
Closed Access | Times Cited: 16
Neural plasticity and depression treatment
Yubing Wang, Ning‐Ning Song, Yu‐Qiang Ding, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 160-184
Open Access | Times Cited: 15
Modulatory effect of n-3 polyunsaturated fatty acids on depressive-like behaviors in rats with chronic sleep deprivation: potential involvement of melatonin receptor pathway and brain lipidome
Chia‐Hsuan Chang, Hua-Chien Wu, Yin-Ru Hsieh, et al.
Food & Function (2023) Vol. 14, Iss. 13, pp. 5977-5993
Closed Access | Times Cited: 9
Synergistic effects of melatonin and hydrogen sulfide in alleviating cognitive decline and BDNF dysregulation in a rat model of depression
Samir Bikri, Fath Nada, El Aboubi Meriam, et al.
Egyptian Journal of Basic and Applied Sciences (2024) Vol. 11, Iss. 1, pp. 334-353
Open Access | Times Cited: 3
Promising new pharmacological targets for depression: The search for efficacy
Lucila Emiko Tsugiyama, Ruan Carlos Macêdo de Moraes, Yaslle Andrade Cavalcante Moraes, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103804-103804
Closed Access | Times Cited: 8
Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials
Zhaoyang Huang, Shuqin Zhan, Chunyan Chen, et al.
SLEEP (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 7
Ramelteon protects against social defeat stress-associated abnormal behaviors
Chao‐Wei Chen, Wei‐Lan Yeh, Vichuda Charoensaensuk, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 241, pp. 173794-173794
Closed Access | Times Cited: 2
Melatonin and blood pressure: a narrative review
O. Serhiyenko, V.B. Sehin, Vitaliy Kuznets, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2024) Vol. 20, Iss. 3, pp. 218-224
Open Access | Times Cited: 2
Melatonin as a Coadjuvant in the Treatment of Patients with Fibromyalgia
David González, Laura López‐Pingarrón, M. Yolanda Castaño, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1964-1964
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top